Skip to content

Study on the superiority of flexible cystoscope in controlling adverse reactions of cystoscopy

Study on the superiority of flexible cystoscope in controlling adverse reactions of cystoscopy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086327
Enrollment
Unknown
Registered
2024-06-28
Start date
2024-07-01
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder tumor

Interventions

Control group:Patients used conventional rigid cystoscopy.
Intervention group:Patients used a flexible bladder scope.

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)Adult male and female patients between the ages of 18 and 75. 2)Patients who are clinically diagnosed to require cystoscopy, including but not limited to bladder diverticulum, bladder stones, bladder tumors and other diseases diagnosed or treated. 3)Patients were able to understand the content of the study and voluntarily signed the informed consent form. 4)Patients are in good physical condition, without serious cardiac, hepatic or renal dysfunction, and without abnormal coagulation function. 5)Patients have not received cystoscopy in the past three months.

Exclusion criteria

Exclusion criteria: 1)Pregnant or nursing women. 2)Patients with known hypersensitivity to materials or medications used in cystoscopy. 3)Patients with uncontrolled urinary tract infections or other acute urinary tract disorders. 4)Patients with a history of severe mental illness or cognitive dysfunction that prevents them from cooperating in the completion of the study. 5)Patients with contraindications to cystoscopy, such as severe urethral stricture and bladder neck obstruction. 6)Patients who may not be expected to complete all follow-up visits during the study period.

Design outcomes

Primary

MeasureTime frame
White blood cells;Neutrophils;Lymphocytes;systemic immune-inflammatory index;neutrophil-lymphocyte ratio;platelet-lymphocyte ratio;

Secondary

MeasureTime frame
Postoperative Quality of Life Questionnaire;Postoperative Function Evaluation;Postoperative Life Satisfaction Scale;Postoperative Pain Assessment Scale;

Countries

China

Contacts

Public ContactJiayu Liu

The First Affiliated Hospital of Chongqing Medical University

urologistliu2022@163.com+86 186 9668 2178

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026